QQ客服 官方微博 反馈留言

	Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.
	Yu, Jinming; Meng, Xue; Wang, Jian Hua; Sun, Xindong; Wang, Lv Hua; Ye, Ming; Feng, Ping Bo; Zhu, Guang Ying; Lu, You; Han, Chun
	2012
卷号	30期号:15
ISSN号	0732-183X
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6707047
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yu, Jinming,Meng, Xue,Wang, Jian Hua,et al. Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.[J],2012,30(15).
APA	Yu, Jinming.,Meng, Xue.,Wang, Jian Hua.,Sun, Xindong.,Wang, Lv Hua.,...&Liao, Zhongxing X..(2012).Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study..,30(15).
MLA	Yu, Jinming,et al."Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.".30.15(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。